Abstract Few therapeutic options for treating neurological diseases are currently available due to the extremely selective nature of the blood-brain barrier (BBB), which strongly limits drug delivery from the systemic circulation into the central nervous system
7g) to expose the cBMAT and placed into a 96-well plate as follows: first well C6/C11, second well C7/C10 and third well C8/C9
Thus, the review will be carefully interpreted regarding differences in experimental design, internal validity, quality of evidence, and risk of bias to allow the results of studies based on animal models to support future clinical trials [31]
Cells use NAD+ to get energy from fuel sources like glucose, amino acids, and fatty acids
Do Nascimento Dias et al., 2020), we observed a noticeable decrease in the metabolic activity of mature biofilms at a peptide concentration approximately 15-fold or 8-fold higher compared to its effectiveness against yeast-like or biofilm-initiating cells
